Introduction to the Special Issue “Biological Efficacy of Natural and Chemically Modified Products against Oral Inflammatory Lesions”
Abstract
1. Antiviral and Antibacterial Agents
2. Kampo Medicine and Constitutive Plant Extracts
3. Protection and Regeneration Mechanism
4. Application of Metabolomics and QSAR
References
- Asai, D.; Nakashima, H. Pathogenic Viruses Commonly Present in the Oral Cavity and Relevant Antiviral Compounds Derived from Natural Products. Medicines 2018, 5, 120. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kanamoto, T.; Terakubo, S.; Nakashima, H. Antimicrobial Susceptibilities of Oral Isolates of Abiotrophia and Granulicatella According to the Consensus Guidelines for Fastidious Bacteria. Medicines 2018, 5, 129. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Shuji Watanabe, S.; Toyama, T.; Sato, T.; Suzuki, M.; Morozumi, A.; Sakagami, H.; Hamada, N. Kampo Therapies and the Use of Herbal Medicines in the Dentistry in Japan. Medicines 2019, 6, 34. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sunagawa, M.; Yamaguchi, K.; Tsukada, M.; Ebihara, N.; Ikemoto, H.; Hisamitsu, T. Kampo (Traditional Japanese Herbal) Formulae for Treatment of Stomatitis and Oral Mucositis. Medicines 2018, 5, 130. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hara, Y.; Shiratuchi, H.; Kaneko, T.; Sakagami, H. Search for Drugs Used in Hospitals to Treat Stomatitis. Medicines 2019, 6, 19. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ara, T.; Nakatani, S.; Kobata, K.; Sogawa, N.; Sogawa, C. The Biological Efficacy of Natural Products against Acute and Chronic Inflammatory Diseases in the Oral Region. Medicines 2018, 5, 122. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Edo, Y.; Otaki, A.; Asano, K. Quercetin Enhances the Thioredoxin Production of Nasal Epithelial Cells In Vitro and In Vivo. Medicines 2018, 5, 124. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Moritani, N.H.; Hara, E.S.; Kubota, S. New Functions of Classical Compounds against Orofacial Inflammatory Lesions. Medicines 2018, 5, 118. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sakagami, H.; Sugimoto, M.; Kanda, Y.; Murakami, Y.; Amano, O.; Saitoh, J.; Kochi, A. Changes in Metabolic Profiles of Human Oral Cells by Benzylidene Ascorbates and Eugenol. Medicines 2018, 5, 116. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sakagami, H.; Watanabe, T.; Hoshino, T.; Suda, N.; Mori, K.; Yasui, T.; Yamauchi, N.; Kashiwagi, H.; Gomi, T.; Oizumi, T.; et al. Recent Progress of Basic Studies of Natural Products and Their Dental Application. Medicines 2019, 6, 4. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Nagai, J.; Imamura, M.; Sakagami, H.; Uesawa, Y. QSAR Prediction Model to Search for Compounds with Selective Cytotoxicity Against Oral Cell Cancer. Medicines 2019, 6, 45. [Google Scholar] [CrossRef] [Scilit] [PubMed]

| Keyword B | Number of Cited References | |||||
|---|---|---|---|---|---|---|
| Keyword A | ||||||
| Stomatitis | Herpes Stomatitis | Aphthous Stomatitis | Oral Inflammation | Periodontitis | Gingivitis | |
| Total | 28,542 (100) | 1935 (100) | 3781 (100) | 35,354 (100) | 37,596 (100) | 13,902(100) |
| Survey 1: Age-related citation rate | ||||||
| Elderly | 7695 (27) | 349 (18) | 1081 (29) | 8677 (25) | 12,603 (34) | 3833 (28) |
| Adult | 10,241 (36) | 599 (31) | 1712 (45) | 12,122 (34) | 17,833 (47) | 6092 (44) |
| Young | 1142 (4) | 88 (5) | 243 (6) | 2413 (7) | 2603 (7) | 1026 (7) |
| Child | 2990 (10) | 434 (22) | 655 (17) | 2708 (8) | 2339 (6) | 2239 (16) |
| Pediatric | 920 (3) | 83 (4) | 235 (6) | 1449 (4) | 660 (2) | 403 (3) |
| Survey 2: Etiology | ||||||
| Virus infection | 6267 (22) | 1582 (82) | 670 (18) | 1437 (4) | 689 (2) | 650 (5) |
| Bacterial infection | 1658 (6) | 174 (9) | 267 (7) | 4529 (13) | 3852 (10) | 1711 (12) |
| Radiotherapy | 1521 (5) | 46 (2) | 54 (1) | 352 (1.0) | 210 (0.6) | 57 (0.4) |
| Inflammation | 1181 (4) | 53 (3) | 164 (4) | N.D. | 5989 (16) | 2669 (19) |
| Autoimmune diseases | 941 (3) | 82 (4) | 248 (7) | 1885 (5) | 709 (2) | 370 (3) |
| Drug-induced | 546 (1.9) | 8 (0.4) | 22 (0.6) | 265 (0.7) | 53 (0.1) | 485 (3) |
| Fungal infection | 1048 (4) | 186 (10) | 164 (4) | 735 (2) | 198 (0.5) | 214 (2) |
| Immune suppression | 428 (1.5) | 55 (3) | 40 (1.1) | 603 (2) | 131 (0.4) | 98 (0.7) |
| Stress | 267 (0.9) | 13 (0.7) | 92 (2) | 2361 (7) | 997 (3) | 227 (1.6) |
| Nutritional deficiencies | 250 (0.9) | 9 (0.5) | 90 (2) | 1243 (4) | 110 (0.3) | 162 (1.2) |
| Genetic background | 202 (0.7) | 4 (0.2) | 40 (1.1) | 240 (0.7) | 450 (1.2) | 47 (0.3) |
| Reactive oxygen species | 119 (0.4) | 0 (0) | 19 (0.5) | 902 (3) | 24 (0.06) | 150 (1.1) |
| Vitamin B deficiency | 107 (0.4) | 0 (0) | 52 (1.4) | 26 (0.1) | 2 (0.01) | 14 (0.1) |
| Cigarette | 60 (0.2) | 9 (0.5) | 18 (0.5) | 250 (0.7) | 323 (0.9) | 82 (0.6) |
| Dental prosthetics | 18 (0.06) | 0 (0) | 1 (0.03) | 19 (0.05) | 42 (0.1) | 14 (0.1) |
| Survey 3: Treatment | ||||||
| Antiviral agent | 3716 (13) | 579 (30) | 116 (3) | 1028 (3) | 321 (0.9) | 102 (0.7) |
| Antibacterial agent | 2333 (8) | 86 (4) | 324 (9) | 3036 (9) | 2907 (8) | 660 (5) |
| Anti-inflammatory agent | 1492 (5) | 66 (3) | 357 (9) | 4975 (14) | 1036 (3) | 474 (3) |
| Steroid | 1234 (4) | 59 (3) | 319 (8) | 2761 (8) | 583 (2) | 342 (2) |
| Natural product | 1105 (4) | 85 (4) | 120 (3) | 2063 (6) | 640 (2) | 314 (2) |
| Trad. Chinese Med. | 54 (0.2) | 2 (0.1) | 24 (0.6) | 349 (1.0) | 45 (0.1) | 3 (0.02) |
| Kampo medicine | 14 (0.05) | 0 (0) | 1 (0.03) | 27 (0.1) | 4 (0.01) | 2 (0.01) |
| Anti-fungal agent | 1029 (4) | 48 (2) | 55 (1.5) | 674 (2) | 128 (0.3) | 37 (0.3) |
| Immunopotentiator | 359 (1.2) | 40 (2) | 127 (3) | 723 (2) | 128 (0.3) | 37 (0.3) |
© 2019 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sakagami, H. Introduction to the Special Issue “Biological Efficacy of Natural and Chemically Modified Products against Oral Inflammatory Lesions”. Medicines 2019, 6, 52. https://doi.org/10.3390/medicines6020052
Sakagami H. Introduction to the Special Issue “Biological Efficacy of Natural and Chemically Modified Products against Oral Inflammatory Lesions”. Medicines. 2019; 6(2):52. https://doi.org/10.3390/medicines6020052
Chicago/Turabian StyleSakagami, Hiroshi. 2019. "Introduction to the Special Issue “Biological Efficacy of Natural and Chemically Modified Products against Oral Inflammatory Lesions”" Medicines 6, no. 2: 52. https://doi.org/10.3390/medicines6020052
APA StyleSakagami, H. (2019). Introduction to the Special Issue “Biological Efficacy of Natural and Chemically Modified Products against Oral Inflammatory Lesions”. Medicines, 6(2), 52. https://doi.org/10.3390/medicines6020052
